In 2001, Jiren Pharmaceutical was just an ordinary decoction piece enterprise, which was unsurprising among hundreds of pharmaceutical enterprises in Bozhou City. Today's Jiren has developed into a pharmaceutical group with 5 subsidiaries. In 2017, the sales revenue exceeded 1.6 billion yuan, and the Shufeng Jiedu capsule alone reached 600 million yuan. "The rapid development of enterprises has benefited from the persistence in technological innovation." Zhu Yuexin said that traditional Chinese medicine is a treasure of the Chinese nation and a gift of China's ancient wisdom to mankind. However, no matter how good things are, innovations are needed, and technological innovations can bring Chinese medicine to life.
In 2009, Jiren Pharmaceuticals developed Shufeng Jiedu Capsules based on private secret recipes and cooperated with a number of scientific institutions and universities through the modernization of traditional Chinese medicine technology. The drug was listed in the National Medical Insurance List as soon as it was launched, and was listed in the National Essential Drug List in 2013. It has been recommended by the National Health and Family Planning Commission and the State Administration of Traditional Chinese Medicine as a variety of influenza prevention and control drugs for several consecutive years. In 2014, the core invention patent of Shufeng Jiedu Capsules won the National Invention Patent Gold Award. No Chinese patent medicine has ever won this award before. "We are under greater pressure when we have won a huge honor. What should the company do in the future? Should it be the gold medal winner or continue to move forward?" Zhu Yuexin told reporters that with the rapid advancement of science and technology, the "old fund" can't afford it. In a few years, in order to seize the opportunity in the future, it must be down-to-earth, and Jiren Pharmaceutical finally chose to "start from scratch."
In 2017, the Provincial Party Committee and the Provincial Government proposed to build Bozhou into the "World Capital of Traditional Chinese Medicine". Modern Chinese medicine is the first industry in Bozhou City. The city makes full use of the favorable policy environment created by the country to vigorously promote the development of Chinese medicine, pioneering and innovating, and continuously promoting the transformation and upgrading of Bozhou's modern Chinese medicine industry.
“Policies are like spring breeze, and everyone is seizing opportunities for development, and Jiren is no exception.” Zhu Yuexin said that Jiren not only spends 30 million yuan in scientific research each year, but also cooperated with Liu Changxiao, an academician of the Chinese Academy of Engineering, to establish an “Academician Workstation”. ". The company is not satisfied with the patent gold award, and has carried out the second research and development of the Shufeng Jiedu capsules, from the origin of the medicinal materials, breeding, planting, picking, to processing, extraction, concentration, drying, preparations, and finished medicines, all of which are standardized and controlled. Conduct mechanism research, quality control, and form industry standards. "This year is the second research and development of Shufeng Jiedu capsule, which won the first prize of Provincial Science and Technology Progress Award." Zhu Yuexin said.
The report of the 19th National Congress of the Communist Party of China stated that “implementing a healthy China strategy and inheriting and developing the cause of traditional Chinese medicine” has clarified the development direction for Bozhou pharmaceutical companies represented by Jiren. "Traditional Chinese medicine is the treasure left by our ancestors. We have the obligation to protect and develop well, persist in scientific research and innovation, improve mechanisms, establish a modern scientific Chinese medicine system, and spread the culture of Chinese medicine to the world." Zhu Yuexin told reporters.